ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
| reSET® | reSET-O® | Somryst® | |
|---|---|---|---|
| Intended use | Increase abstinence and retention in patients with SUD | Increase retention in patients with OUD | Treat patients with chronic insomnia |
| Medical device type | Software as a Medical Device (SaMD) | ||
| Access | Rx only | ||
| Age of treatment | 18+ | 18+ | 22+ |
| Period of use | 12 weeks (90 days) | 12 weeks (84 days) | 9 weeks (63 days) |
| Mechanism of action | Cognitive behavioral therapy (CBT) | ||
| Composition | • 31 core lessons | • 31 core lessons | • 6 cores lessons |
| • 30 keep learning lessons | • 36 keep learning lessons | ||
| User interface | • Software application that requires users to login, go through modules of therapeutic content (text, video, audio) | ||
| • Interacting with device (through quizzes, contingency management, reporting cravings, etc.) | • Interacting with device (through sleep diary and interactive activities, etc.) | ||
| • Receiving prompts/ feedback | |||
| Independence | • Concurrent use with TAU | • Concurrent use with TAU | - |
| • Co-administration with buprenorphine | |||
| Price | $1,665 | $1,500 | $899 ($25 consultation fee) |
SUD: substance use disorder; ODU: opioid use disorder; TAU: treatment as usual; AE: adverse effect